1
|
Yao Y, Ko Y, Grasman G, Raymond JE, Lahann J. The steep road to nonviral nanomedicines: Frequent challenges and culprits in designing nanoparticles for gene therapy. BEILSTEIN JOURNAL OF NANOTECHNOLOGY 2023; 14:351-361. [PMID: 36959977 PMCID: PMC10028570 DOI: 10.3762/bjnano.14.30] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/10/2022] [Accepted: 02/28/2023] [Indexed: 06/18/2023]
Abstract
The potential of therapeutically loaded nanoparticles (NPs) has been successfully demonstrated during the last decade, with NP-mediated nonviral gene delivery gathering significant attention as highlighted by the broad clinical acceptance of mRNA-based COVID-19 vaccines. A significant barrier to progress in this emerging area is the wild variability of approaches reported in published literature regarding nanoparticle characterizations. Here, we provide a brief overview of the current status and outline important concerns regarding the need for standardized protocols to evaluate NP uptake, NP transfection efficacy, drug dose determination, and variability of nonviral gene delivery systems. Based on these concerns, we propose wide adherence to multimodal, multiparameter, and multistudy analysis of NP systems. Adoption of these proposed approaches will ensure improved transparency, provide a better basis for interlaboratory comparisons, and will simplify judging the significance of new findings in a broader context, all critical requirements for advancing the field of nonviral gene delivery.
Collapse
Affiliation(s)
- Yao Yao
- Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA
- School of Dentistry, University of Michigan, Ann Arbor, MI 48109, USA
- Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, USA
| | - Yeongun Ko
- Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA
- Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, USA
- School of Polymer Science and Engineering, Chonnam National University, Buk-gu, Gwangju 61186, South Korea
| | - Grant Grasman
- Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA
- Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, USA
| | - Jeffery E Raymond
- Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA
- Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, USA
| | - Joerg Lahann
- Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA
- Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, USA
| |
Collapse
|
2
|
Guo Y, Mi J, Ye C, Ao Y, Shi M, Shan Z, Li B, Chen Z, Chen Z, Vasilev K, Xiao Y. A practical guide to promote informatics-driven efficient biotopographic material development. Bioact Mater 2022; 8:515-528. [PMID: 34541417 PMCID: PMC8433058 DOI: 10.1016/j.bioactmat.2021.06.013] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2021] [Revised: 05/31/2021] [Accepted: 06/10/2021] [Indexed: 01/14/2023] Open
Abstract
Micro/nano topographic structures have shown great utility in many biomedical areas including cell therapies, tissue engineering, and implantable devices. Computer-assisted informatics methods hold great promise for the design of topographic structures with targeted properties for a specific medical application. To benefit from these methods, researchers and engineers require a highly reusable "one structural parameter - one set of cell responses" database. However, existing confounding factors in topographic cell culture devices seriously impede the acquisition of this kind of data. Through carefully dissecting the confounding factors and their possible reasons for emergence, we developed corresponding guideline requirements for topographic cell culture device development to remove or control the influence of such factors. Based on these requirements, we then suggested potential strategies to meet them. In this work, we also experimentally demonstrated a topographic cell culture device with controlled confounding factors based on these guideline requirements and corresponding strategies. A "guideline for the development of topographic cell culture devices" was summarized to instruct researchers to develop topographic cell culture devices with the confounding factors removed or well controlled. This guideline aims to promote the establishment of a highly reusable "one structural parameter - one set of cell responses" database that could facilitate the application of informatics methods, such as artificial intelligence, in the rational design of future biotopographic structures with high efficacy.
Collapse
Affiliation(s)
- Yuanlong Guo
- Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University and Guangdong Research Center for Dental and Cranial Rehabilitation and Material Engineering, Guangzhou, 510055, China
| | - Jiaomei Mi
- Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University and Guangdong Research Center for Dental and Cranial Rehabilitation and Material Engineering, Guangzhou, 510055, China
| | - Chen Ye
- Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University and Guangdong Research Center for Dental and Cranial Rehabilitation and Material Engineering, Guangzhou, 510055, China
| | - Yong Ao
- Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University and Guangdong Research Center for Dental and Cranial Rehabilitation and Material Engineering, Guangzhou, 510055, China
| | - Mengru Shi
- Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University and Guangdong Research Center for Dental and Cranial Rehabilitation and Material Engineering, Guangzhou, 510055, China
| | - Zhengjie Shan
- Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University and Guangdong Research Center for Dental and Cranial Rehabilitation and Material Engineering, Guangzhou, 510055, China
| | - Bingzhi Li
- Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University and Guangdong Research Center for Dental and Cranial Rehabilitation and Material Engineering, Guangzhou, 510055, China
| | - Zetao Chen
- Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University and Guangdong Research Center for Dental and Cranial Rehabilitation and Material Engineering, Guangzhou, 510055, China
| | - Zhuofan Chen
- Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University and Guangdong Research Center for Dental and Cranial Rehabilitation and Material Engineering, Guangzhou, 510055, China
| | - Krasimir Vasilev
- Academic Unit of Science, Technology, Engineering and Mathematics (STEM), University of South Australia, Mawson Lakes, SA, 5095, Australia
| | - Yin Xiao
- Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, 4059, Australia
| |
Collapse
|
3
|
Summers HD, Gomes CP, Varela-Moreira A, Spencer AP, Gomez-Lazaro M, Pêgo AP, Rees P. Data-Driven Modeling of the Cellular Pharmacokinetics of Degradable Chitosan-Based Nanoparticles. NANOMATERIALS 2021; 11:nano11102606. [PMID: 34685047 PMCID: PMC8538870 DOI: 10.3390/nano11102606] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/14/2021] [Revised: 09/28/2021] [Accepted: 09/29/2021] [Indexed: 02/05/2023]
Abstract
Nanoparticle drug delivery vehicles introduce multiple pharmacokinetic processes, with the delivery, accumulation, and stability of the therapeutic molecule influenced by nanoscale processes. Therefore, considering the complexity of the multiple interactions, the use of data-driven models has critical importance in understanding the interplay between controlling processes. We demonstrate data simulation techniques to reproduce the time-dependent dose of trimethyl chitosan nanoparticles in an ND7/23 neuronal cell line, used as an in vitro model of native peripheral sensory neurons. Derived analytical expressions of the mean dose per cell accurately capture the pharmacokinetics by including a declining delivery rate and an intracellular particle degradation process. Comparison with experiment indicates a supply time constant, τ = 2 h. and a degradation rate constant, b = 0.71 h−1. Modeling the dose heterogeneity uses simulated data distributions, with time dependence incorporated by transforming data-bin values. The simulations mimic the dynamic nature of cell-to-cell dose variation and explain the observed trend of increasing numbers of high-dose cells at early time points, followed by a shift in distribution peak to lower dose between 4 to 8 h and a static dose profile beyond 8 h.
Collapse
Affiliation(s)
- Huw D. Summers
- Department of Biomedical Engineering, Swansea University, Swansea SA1 8QQ, UK;
- Correspondence:
| | - Carla P. Gomes
- i3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; (C.P.G.); (A.V.-M.); (A.P.S.); (M.G.-L.); (A.P.P.)
- Instituto de Engenharia Biomédica INEB, Universidade do Porto, 4200-135 Porto, Portugal
- Faculdade de Engenharia da Universidade do Porto (FEUP), Universidade do Porto, 4200-465 Porto, Portugal
| | - Aida Varela-Moreira
- i3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; (C.P.G.); (A.V.-M.); (A.P.S.); (M.G.-L.); (A.P.P.)
- Instituto de Engenharia Biomédica INEB, Universidade do Porto, 4200-135 Porto, Portugal
| | - Ana P. Spencer
- i3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; (C.P.G.); (A.V.-M.); (A.P.S.); (M.G.-L.); (A.P.P.)
- Instituto de Engenharia Biomédica INEB, Universidade do Porto, 4200-135 Porto, Portugal
- Faculdade de Engenharia da Universidade do Porto (FEUP), Universidade do Porto, 4200-465 Porto, Portugal
| | - Maria Gomez-Lazaro
- i3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; (C.P.G.); (A.V.-M.); (A.P.S.); (M.G.-L.); (A.P.P.)
- Instituto de Engenharia Biomédica INEB, Universidade do Porto, 4200-135 Porto, Portugal
| | - Ana P. Pêgo
- i3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; (C.P.G.); (A.V.-M.); (A.P.S.); (M.G.-L.); (A.P.P.)
- Instituto de Engenharia Biomédica INEB, Universidade do Porto, 4200-135 Porto, Portugal
- Faculdade de Engenharia da Universidade do Porto (FEUP), Universidade do Porto, 4200-465 Porto, Portugal
- Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, 4050-313 Porto, Portugal
| | - Paul Rees
- Department of Biomedical Engineering, Swansea University, Swansea SA1 8QQ, UK;
| |
Collapse
|
4
|
Ximendes E, Benayas A, Jaque D, Marin R. Quo Vadis, Nanoparticle-Enabled In Vivo Fluorescence Imaging? ACS NANO 2021; 15:1917-1941. [PMID: 33465306 DOI: 10.1021/acsnano.0c08349] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
The exciting advancements that we are currently witnessing in terms of novel materials and synthesis approaches are leading to the development of colloidal nanoparticles (NPs) with increasingly greater tunable properties. We have now reached a point where it is possible to synthesize colloidal NPs with functionalities tailored to specific societal demands. The impact of this new wave of colloidal NPs has been especially important in the field of biomedicine. In that vein, luminescent NPs with improved brightness and near-infrared working capabilities have turned out to be optimal optical probes that are capable of fast and high-resolution in vivo imaging. However, luminescent NPs have thus far only reached a limited portion of their potential. Although we believe that the best is yet to come, the future might not be as bright as some of us think (and have hoped!). In particular, translation of NP-based fluorescence imaging from preclinical studies to clinics is not straightforward. In this Perspective, we provide a critical assessment and highlight promising research avenues based on the latest advances in the fields of luminescent NPs and imaging technologies. The disillusioned outlook we proffer herein might sound pessimistic at first, but we consider it necessary to avoid pursuing "pipe dreams" and redirect the efforts toward achievable-yet ambitious-goals.
Collapse
Affiliation(s)
- Erving Ximendes
- Fluorescence Imaging Group, Departamento de Fısica de Materiales, Facultad de Ciencias, Universidad Autónoma de Madrid, C/Francisco Tomás y Valiente 7, Madrid 28049, Spain
- Nanobiology Group, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ctra. Colmenar km. 9.100, Madrid 28034, Spain
| | - Antonio Benayas
- Fluorescence Imaging Group, Departamento de Fısica de Materiales, Facultad de Ciencias, Universidad Autónoma de Madrid, C/Francisco Tomás y Valiente 7, Madrid 28049, Spain
- Nanobiology Group, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ctra. Colmenar km. 9.100, Madrid 28034, Spain
| | - Daniel Jaque
- Fluorescence Imaging Group, Departamento de Fısica de Materiales, Facultad de Ciencias, Universidad Autónoma de Madrid, C/Francisco Tomás y Valiente 7, Madrid 28049, Spain
- Nanobiology Group, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ctra. Colmenar km. 9.100, Madrid 28034, Spain
| | - Riccardo Marin
- Fluorescence Imaging Group, Departamento de Fısica de Materiales, Facultad de Ciencias, Universidad Autónoma de Madrid, C/Francisco Tomás y Valiente 7, Madrid 28049, Spain
| |
Collapse
|
5
|
Anık Ü, Timur S, Dursun Z. Recent pros and cons of nanomaterials in drug delivery systems. INT J POLYM MATER PO 2020. [DOI: 10.1080/00914037.2019.1655753] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- Ülkü Anık
- Faculty of Science, Chemistry Department, Mugla Sitki Kocman University, Mugla, Turkey
| | - Suna Timur
- Faculty of Science, Biochemistry Department, Ege University, Bornova, Izmir, Turkey
| | - Zekerya Dursun
- Faculty of Science, Chemistry Department, Ege University, Bornova, Izmir, Turkey
| |
Collapse
|
6
|
Nelissen I, Haase A, Anguissola S, Rocks L, Jacobs A, Willems H, Riebeling C, Luch A, Piret JP, Toussaint O, Trouiller B, Lacroix G, Gutleb AC, Contal S, Diabaté S, Weiss C, Lozano-Fernández T, González-Fernández Á, Dusinska M, Huk A, Stone V, Kanase N, Nocuń M, Stępnik M, Meschini S, Ammendolia MG, Lewinski N, Riediker M, Venturini M, Benetti F, Topinka J, Brzicova T, Milani S, Rädler J, Salvati A, Dawson KA. Improving Quality in Nanoparticle-Induced Cytotoxicity Testing by a Tiered Inter-Laboratory Comparison Study. NANOMATERIALS 2020; 10:nano10081430. [PMID: 32707981 PMCID: PMC7466672 DOI: 10.3390/nano10081430] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/25/2020] [Revised: 07/13/2020] [Accepted: 07/17/2020] [Indexed: 12/28/2022]
Abstract
The quality and relevance of nanosafety studies constitute major challenges to ensure their key role as a supporting tool in sustainable innovation, and subsequent competitive economic advantage. However, the number of apparently contradictory and inconclusive research results has increased in the past few years, indicating the need to introduce harmonized protocols and good practices in the nanosafety research community. Therefore, we aimed to evaluate if best-practice training and inter-laboratory comparison (ILC) of performance of the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay for the cytotoxicity assessment of nanomaterials among 15 European laboratories can improve quality in nanosafety testing. We used two well-described model nanoparticles, 40-nm carboxylated polystyrene (PS-COOH) and 50-nm amino-modified polystyrene (PS-NH2). We followed a tiered approach using well-developed standard operating procedures (SOPs) and sharing the same cells, serum and nanoparticles. We started with determination of the cell growth rate (tier 1), followed by a method transfer phase, in which all laboratories performed the first ILC on the MTS assay (tier 2). Based on the outcome of tier 2 and a survey of laboratory practices, specific training was organized, and the MTS assay SOP was refined. This led to largely improved intra- and inter-laboratory reproducibility in tier 3. In addition, we confirmed that PS-COOH and PS-NH2 are suitable negative and positive control nanoparticles, respectively, to evaluate impact of nanomaterials on cell viability using the MTS assay. Overall, we have demonstrated that the tiered process followed here, with the use of SOPs and representative control nanomaterials, is necessary and makes it possible to achieve good inter-laboratory reproducibility, and therefore high-quality nanotoxicological data.
Collapse
Affiliation(s)
- Inge Nelissen
- Health Department, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium; (A.J.); (H.W.)
- Correspondence: ; Tel.: +32-14-335107
| | - Andrea Haase
- Department of Chemicals and Product Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany; (A.H.); (C.R.); (A.L.)
| | - Sergio Anguissola
- Centre for BioNano Interactions, University College Dublin (UCD), Belfield, Dublin 4, Ireland; (S.A.); (L.R.); (A.S.); (K.A.D.)
- Charles River Laboratories, Carrowntreila, Ballina, Co. Mayo, Ireland
| | - Louise Rocks
- Centre for BioNano Interactions, University College Dublin (UCD), Belfield, Dublin 4, Ireland; (S.A.); (L.R.); (A.S.); (K.A.D.)
- Science Foundation Ireland, Three Park Place, Hatch Street Upper, Dublin 2, Ireland
| | - An Jacobs
- Health Department, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium; (A.J.); (H.W.)
| | - Hanny Willems
- Health Department, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium; (A.J.); (H.W.)
| | - Christian Riebeling
- Department of Chemicals and Product Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany; (A.H.); (C.R.); (A.L.)
| | - Andreas Luch
- Department of Chemicals and Product Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany; (A.H.); (C.R.); (A.L.)
| | - Jean-Pascal Piret
- Research Unit in Cellular Biology (URBC), Namur Nanosafety Center (NNC), Namur Research Institute for Life Sciences (NARILIS), University of Namur (UNamur), rue de Bruxelles 61, 5000 Namur, Belgium;
| | - Olivier Toussaint
- Research Unit in Cellular Biology (URBC), Namur Nanosafety Center (NNC), Namur Research Institute for Life Sciences (NARILIS), University of Namur (UNamur), rue de Bruxelles 61, 5000 Namur, Belgium;
| | - Bénédicte Trouiller
- Experimental Toxicology Unit, Institut National de l’Environnement Industriel et des Risques (INERIS), Parc Alata, BP2, 60550 Verneuil-en-Halatte, France; (B.T.); (G.L.)
| | - Ghislaine Lacroix
- Experimental Toxicology Unit, Institut National de l’Environnement Industriel et des Risques (INERIS), Parc Alata, BP2, 60550 Verneuil-en-Halatte, France; (B.T.); (G.L.)
| | - Arno C. Gutleb
- Environmental Research and Innovation (ERIN) Department, Luxembourg Institute of Science and Technology (LIST), 41, rue du Brill, L-4422 Belvaux, Luxembourg; (A.C.G.); (S.C.)
| | - Servane Contal
- Environmental Research and Innovation (ERIN) Department, Luxembourg Institute of Science and Technology (LIST), 41, rue du Brill, L-4422 Belvaux, Luxembourg; (A.C.G.); (S.C.)
| | - Silvia Diabaté
- Institute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany; (S.D.); (C.W.)
| | - Carsten Weiss
- Institute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany; (S.D.); (C.W.)
| | - Tamara Lozano-Fernández
- Biomedical Research Center (CINBIO), University of Vigo, Campus Lagoas Marcosende, 36310 Vigo, Spain; (T.L.-F.); (Ã.G.-F.)
- Nanoimmunotech SL, Edificio CITEXVI Fonte das Abelleiras s/n, Campus Universitario de Vigo, 36310 Vigo, Pontevedra, Spain
| | - África González-Fernández
- Biomedical Research Center (CINBIO), University of Vigo, Campus Lagoas Marcosende, 36310 Vigo, Spain; (T.L.-F.); (Ã.G.-F.)
- Instituto de Investigación Sanitaria Galicia Sur (IISGS), Hospital Álvaro Cunqueiro, Estrada Clara Campoamor 341, Babio – Beade, 36312 Vigo, Spain
| | - Maria Dusinska
- Health Effects Laboratory, Department of Environmental Chemistry, Norwegian Institute for Air Research (NILU), Instituttveien 18, 2007 Kjeller, Norway; (M.D.); (A.H.)
| | - Anna Huk
- Health Effects Laboratory, Department of Environmental Chemistry, Norwegian Institute for Air Research (NILU), Instituttveien 18, 2007 Kjeller, Norway; (M.D.); (A.H.)
- Gentian Diagnostics AS, Bjørnåsveien 5, 1596 Moss, Norway
| | - Vicki Stone
- School of Life Sciences, Heriot-Watt University (HWU), Riccarton Campus, Edinburgh EH14 4AS, UK; (V.S.); (N.K.)
| | - Nilesh Kanase
- School of Life Sciences, Heriot-Watt University (HWU), Riccarton Campus, Edinburgh EH14 4AS, UK; (V.S.); (N.K.)
| | - Marek Nocuń
- Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine (NIOM), 91-348 Łódź, Poland; (M.N.); (M.S.)
- SEQme s.r.o., Dlouha 176, 26301 Dobris, Czech Republic
| | - Maciej Stępnik
- Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine (NIOM), 91-348 Łódź, Poland; (M.N.); (M.S.)
| | - Stefania Meschini
- National Center for Drug Research and Evaluation and National Center of Innovative Technologies for Public Health, Istituto Superiore di Sanità (ISS), Viale Regina Elena, 299 Rome, Italy; (S.M.); (M.G.A.)
| | - Maria Grazia Ammendolia
- National Center for Drug Research and Evaluation and National Center of Innovative Technologies for Public Health, Istituto Superiore di Sanità (ISS), Viale Regina Elena, 299 Rome, Italy; (S.M.); (M.G.A.)
| | - Nastassja Lewinski
- Institute for Work and Health (IST), University of Lausanne and University of Geneva, Route de la Corniche 2, 1066 Epalinges-Lausanne, Switzerland; (N.L.); (M.R.)
- Department of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, VA 23284, USA
| | - Michael Riediker
- Institute for Work and Health (IST), University of Lausanne and University of Geneva, Route de la Corniche 2, 1066 Epalinges-Lausanne, Switzerland; (N.L.); (M.R.)
- Swiss Centre for Occupational and Environmental Health (SCOEH), Binzhofstrasse 87, 8404 Winterthur, Switzerland
- School of Materials Science & Engineering, Nanyang Technological University, Block N4.1, Nanyang Avenue, Singapore 639798, Singapore
| | - Marco Venturini
- ECAMRICERT SRL, European Center for the Sustainable Impact of Nanotechnology (ECSIN), Corso Stati Uniti 4, 35127 Padova, Italy; (M.V.); (F.B.)
| | - Federico Benetti
- ECAMRICERT SRL, European Center for the Sustainable Impact of Nanotechnology (ECSIN), Corso Stati Uniti 4, 35127 Padova, Italy; (M.V.); (F.B.)
| | - Jan Topinka
- Institute of Experimental Medicine (IEM), Czech Academy of Sciences, Videnska 1083, 14220 Prague 4, Czech Republic; (J.T.); (T.B.)
| | - Tana Brzicova
- Institute of Experimental Medicine (IEM), Czech Academy of Sciences, Videnska 1083, 14220 Prague 4, Czech Republic; (J.T.); (T.B.)
- Faculty of Safety Engineering, VSB-Technical University of Ostrava, Lumirova 13, 70030 Ostrava-Vyskovice, Czech Republic
| | - Silvia Milani
- Faculty of Physics and Center for NanoScience, Ludwig-Maximilians-Universität, Geshwister-Scholl-Platz 1, 80539 Munich, Germany; (S.M.); (J.R.)
| | - Joachim Rädler
- Faculty of Physics and Center for NanoScience, Ludwig-Maximilians-Universität, Geshwister-Scholl-Platz 1, 80539 Munich, Germany; (S.M.); (J.R.)
| | - Anna Salvati
- Centre for BioNano Interactions, University College Dublin (UCD), Belfield, Dublin 4, Ireland; (S.A.); (L.R.); (A.S.); (K.A.D.)
- Groningen Research Institute of Pharmacy, University of Groningen, A. Deusinglaan 1, 9713AV Groningen, The Netherlands
| | - Kenneth A. Dawson
- Centre for BioNano Interactions, University College Dublin (UCD), Belfield, Dublin 4, Ireland; (S.A.); (L.R.); (A.S.); (K.A.D.)
| |
Collapse
|
7
|
Casals E, Zeng M, Parra-Robert M, Fernández-Varo G, Morales-Ruiz M, Jiménez W, Puntes V, Casals G. Cerium Oxide Nanoparticles: Advances in Biodistribution, Toxicity, and Preclinical Exploration. SMALL (WEINHEIM AN DER BERGSTRASSE, GERMANY) 2020; 16:e1907322. [PMID: 32329572 DOI: 10.1002/smll.201907322] [Citation(s) in RCA: 65] [Impact Index Per Article: 16.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/15/2019] [Revised: 02/08/2020] [Accepted: 03/24/2020] [Indexed: 06/11/2023]
Abstract
Antioxidant nanoparticles have recently gained tremendous attention for their enormous potential in biomedicine. However, discrepant reports of either medical benefits or toxicity, and lack of reproducibility of many studies, generate uncertainties delaying their effective implementation. Herein, the case of cerium oxide is considered, a well-known catalyst in the petrochemistry industry and one of the first antioxidant nanoparticles proposed for medicine. Like other nanoparticles, it is now described as a promising therapeutic alternative, now as threatening to health. Sources of these discrepancies and how this analysis helps to overcome contradictions found for other nanoparticles are summarized and discussed. For the context of this analysis, what has been reported in the liver is reviewed, where many diseases are related to oxidative stress. Since well-dispersed nanoparticles passively accumulate in liver, it represents a major testing field for the study of new nanomedicines and their clinical translation. Even more, many contradictory works have reported in liver either cerium-oxide-associated toxicity or protection against oxidative stress and inflammation. Based on this, finally, the intention is to propose solutions to design improved nanoparticles that will work more precisely in medicine and safely in society.
Collapse
Affiliation(s)
- Eudald Casals
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen, 529020, China
| | - Muling Zeng
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen, 529020, China
| | - Marina Parra-Robert
- Service of Biochemistry and Molecular Genetics, Hospital Clinic Universitari, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain
| | - Guillermo Fernández-Varo
- Service of Biochemistry and Molecular Genetics, Hospital Clinic Universitari, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain
- Departament of Biomedicine, University of Barcelona, Barcelona, 08036, Spain
| | - Manuel Morales-Ruiz
- Service of Biochemistry and Molecular Genetics, Hospital Clinic Universitari, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain
- Departament of Biomedicine, University of Barcelona, Barcelona, 08036, Spain
- Working Group for the Biochemical Assessment of Hepatic Disease-SEQC ML, Barcelona, 08036, Spain
| | - Wladimiro Jiménez
- Service of Biochemistry and Molecular Genetics, Hospital Clinic Universitari, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain
- Departament of Biomedicine, University of Barcelona, Barcelona, 08036, Spain
| | - Víctor Puntes
- Vall d'Hebron Research Institute (VHIR), Barcelona, 08035, Spain
- Institut Català de Nanociència i Nanotecnologia (ICN2), CSIC, The Barcelona Institute of Science and Technology (BIST), Campus UAB, Bellaterra, Barcelona, 08193, Spain
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, 08010, Spain
| | - Gregori Casals
- Service of Biochemistry and Molecular Genetics, Hospital Clinic Universitari, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain
- Working Group for the Biochemical Assessment of Hepatic Disease-SEQC ML, Barcelona, 08036, Spain
| |
Collapse
|
8
|
Essa D, Kondiah PPD, Choonara YE, Pillay V. The Design of Poly(lactide-co-glycolide) Nanocarriers for Medical Applications. Front Bioeng Biotechnol 2020; 8:48. [PMID: 32117928 PMCID: PMC7026499 DOI: 10.3389/fbioe.2020.00048] [Citation(s) in RCA: 103] [Impact Index Per Article: 25.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2019] [Accepted: 01/22/2020] [Indexed: 12/19/2022] Open
Abstract
Polymeric biomaterials have found widespread applications in nanomedicine, and poly(lactide-co-glycolide), (PLGA) in particular has been successfully implemented in numerous drug delivery formulations due to its synthetic malleability and biocompatibility. However, the need for preconception in these formulations is increasing, and this can be achieved by selection and elimination of design variables in order for these systems to be tailored for their specific applications. The starting materials and preparation methods have been shown to influence various parameters of PLGA-based nanocarriers and their implementation in drug delivery systems, while the implementation of computational simulations as a component of formulation studies can provide valuable information on their characteristics. This review provides a critical summary of the synthesis and applications of PLGA-based systems in bio-medicine and outlines experimental and computational design considerations of these systems.
Collapse
Affiliation(s)
| | | | | | - Viness Pillay
- Wits Advanced Drug Delivery Platform, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| |
Collapse
|
9
|
Francia V, Montizaan D, Salvati A. Interactions at the cell membrane and pathways of internalization of nano-sized materials for nanomedicine. BEILSTEIN JOURNAL OF NANOTECHNOLOGY 2020; 11:338-353. [PMID: 32117671 PMCID: PMC7034226 DOI: 10.3762/bjnano.11.25] [Citation(s) in RCA: 81] [Impact Index Per Article: 20.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/30/2019] [Accepted: 01/27/2020] [Indexed: 05/17/2023]
Abstract
Nano-sized materials have great potential as drug carriers for nanomedicine applications. Thanks to their size, they can exploit the cellular machinery to enter cells and be trafficked intracellularly, thus they can be used to overcome some of the cellular barriers to drug delivery. Nano-sized drug carriers of very different properties can be prepared, and their surface can be modified by the addition of targeting moieties to recognize specific cells. However, it is still difficult to understand how the material properties affect the subsequent interactions and outcomes at cellular level. As a consequence of this, designing targeted drugs remains a major challenge in drug delivery. Within this context, we discuss the current understanding of the initial steps in the interactions of nano-sized materials with cells in relation to nanomedicine applications. In particular, we focus on the difficult interplay between the initial adhesion of nano-sized materials to the cell surface, the potential recognition by cell receptors, and the subsequent mechanisms cells use to internalize them. The factors affecting these initial events are discussed. Then, we briefly describe the different pathways of endocytosis in cells and illustrate with some examples the challenges in understanding how nanomaterial properties, such as size, charge, and shape, affect the mechanisms cells use for their internalization. Technical difficulties in characterizing these mechanisms are presented. A better understanding of the first interactions of nano-sized materials with cells will help to design nanomedicines with improved targeting.
Collapse
Affiliation(s)
- Valentina Francia
- Groningen Research Institute of Pharmacy, University of Groningen, 9713AV Groningen, Netherlands
| | - Daphne Montizaan
- Groningen Research Institute of Pharmacy, University of Groningen, 9713AV Groningen, Netherlands
| | - Anna Salvati
- Groningen Research Institute of Pharmacy, University of Groningen, 9713AV Groningen, Netherlands
| |
Collapse
|
10
|
Algar WR, Jeen T, Massey M, Peveler WJ, Asselin J. Small Surface, Big Effects, and Big Challenges: Toward Understanding Enzymatic Activity at the Inorganic Nanoparticle-Substrate Interface. LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2019; 35:7067-7091. [PMID: 30415548 DOI: 10.1021/acs.langmuir.8b02733] [Citation(s) in RCA: 30] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
Enzymes are important biomarkers for molecular diagnostics and targets for the action of drugs. In turn, inorganic nanoparticles (NPs) are of interest as materials for biological assays, biosensors, cellular and in vivo imaging probes, and vectors for drug delivery and theranostics. So how does an enzyme interact with a NP, and what are the outcomes of multivalent conjugation of its substrate to a NP? This invited feature article addresses the current state of the art in answering this question. Using gold nanoparticles (Au NPs) and semiconductor quantum dots (QDs) as illustrative materials, we discuss aspects of enzyme structure-function and the properties of NP interfaces and surface chemistry that determine enzyme-NP interactions. These aspects render the substrate-on-NP configurations far more complex and heterogeneous than the conventional turnover of discrete substrate molecules in bulk solution. Special attention is also given to the limitations of a standard kinetic analysis of the enzymatic turnover of these configurations, the need for a well-defined model of turnover, and whether a "hopping" model can account for behaviors such as the apparent acceleration of enzyme activity. A detailed and predictive understanding of how enzymes turn over multivalent NP-substrate conjugates will require a convergence of many concepts and tools from biochemistry, materials, and interface science. In turn, this understanding will help to enable rational, optimized, and value-added designs of NP bioconjugates for biomedical and clinical applications.
Collapse
Affiliation(s)
- W Russ Algar
- Department of Chemistry , University of British Columbia , 2036 Main Mall , Vancouver , British Columbia V6T 1Z1 , Canada
| | - Tiffany Jeen
- Department of Chemistry , University of British Columbia , 2036 Main Mall , Vancouver , British Columbia V6T 1Z1 , Canada
| | - Melissa Massey
- Department of Chemistry , University of British Columbia , 2036 Main Mall , Vancouver , British Columbia V6T 1Z1 , Canada
| | - William J Peveler
- Department of Chemistry , University of British Columbia , 2036 Main Mall , Vancouver , British Columbia V6T 1Z1 , Canada
- Division of Biomedical Engineering, School of Engineering , University of Glasgow , Glasgow G12 8LT , United Kingdom
| | - Jérémie Asselin
- Department of Chemistry , University of British Columbia , 2036 Main Mall , Vancouver , British Columbia V6T 1Z1 , Canada
| |
Collapse
|
11
|
Rees P, Wills JW, Brown MR, Barnes CM, Summers HD. The origin of heterogeneous nanoparticle uptake by cells. Nat Commun 2019; 10:2341. [PMID: 31138801 PMCID: PMC6538724 DOI: 10.1038/s41467-019-10112-4] [Citation(s) in RCA: 85] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2018] [Accepted: 04/18/2019] [Indexed: 12/16/2022] Open
Abstract
Understanding nanoparticle uptake by biological cells is fundamentally important to wide-ranging fields from nanotoxicology to drug delivery. It is now accepted that the arrival of nanoparticles at the cell is an extremely complicated process, shaped by many factors including unique nanoparticle physico-chemical characteristics, protein-particle interactions and subsequent agglomeration, diffusion and sedimentation. Sequentially, the nanoparticle internalisation process itself is also complex, and controlled by multiple aspects of a cell's state. Despite this multitude of factors, here we demonstrate that the statistical distribution of the nanoparticle dose per endosome is independent of the initial administered dose and exposure duration. Rather, it is the number of nanoparticle containing endosomes that are dependent on these initial dosing conditions. These observations explain the heterogeneity of nanoparticle delivery at the cellular level and allow the derivation of simple, yet powerful probabilistic distributions that accurately predict the nanoparticle dose delivered to individual cells across a population.
Collapse
Affiliation(s)
- Paul Rees
- Centre for Nanohealth, Swansea University College of Engineering, Fabian Way, Crymlyn Burrows, Swansea, SA1 8EN, UK. .,Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA, 02142, USA.
| | - John W Wills
- Biominerals Research, Cambridge University Department of Veterinary Medicine, School of Biological Sciences, Madingley Road, Cambridge, CB3 0ES, UK.
| | - M Rowan Brown
- Centre for Nanohealth, Swansea University College of Engineering, Fabian Way, Crymlyn Burrows, Swansea, SA1 8EN, UK
| | - Claire M Barnes
- Centre for Nanohealth, Swansea University College of Engineering, Fabian Way, Crymlyn Burrows, Swansea, SA1 8EN, UK
| | - Huw D Summers
- Centre for Nanohealth, Swansea University College of Engineering, Fabian Way, Crymlyn Burrows, Swansea, SA1 8EN, UK
| |
Collapse
|
12
|
Faria M, Björnmalm M, Thurecht KJ, Kent SJ, Parton RG, Kavallaris M, Johnston APR, Gooding JJ, Corrie SR, Boyd BJ, Thordarson P, Whittaker AK, Stevens MM, Prestidge CA, Porter CJH, Parak WJ, Davis TP, Crampin EJ, Caruso F. Minimum information reporting in bio-nano experimental literature. NATURE NANOTECHNOLOGY 2018; 13:777-785. [PMID: 30190620 PMCID: PMC6150419 DOI: 10.1038/s41565-018-0246-4] [Citation(s) in RCA: 381] [Impact Index Per Article: 63.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/06/2018] [Accepted: 07/24/2018] [Indexed: 04/14/2023]
Abstract
Studying the interactions between nanoengineered materials and biological systems plays a vital role in the development of biological applications of nanotechnology and the improvement of our fundamental understanding of the bio-nano interface. A significant barrier to progress in this multidisciplinary area is the variability of published literature with regards to characterizations performed and experimental details reported. Here, we suggest a 'minimum information standard' for experimental literature investigating bio-nano interactions. This standard consists of specific components to be reported, divided into three categories: material characterization, biological characterization and details of experimental protocols. Our intention is for these proposed standards to improve reproducibility, increase quantitative comparisons of bio-nano materials, and facilitate meta analyses and in silico modelling.
Collapse
Affiliation(s)
- Matthew Faria
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria, Australia
- Systems Biology Laboratory, School of Mathematics and Statistics and Melbourne School of Engineering, The University of Melbourne, Parkville, Victoria, Australia
| | - Mattias Björnmalm
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria, Australia
- Department of Materials, Imperial College London, London, UK
- Department of Bioengineering, and Institute of Biomedical Engineering, Imperial College London, London, UK
| | - Kristofer J Thurecht
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia
- Centre for Advanced Imaging, The University of Queensland, Brisbane, Queensland, Australia
| | - Stephen J Kent
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville, Victoria, Australia
| | - Robert G Parton
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
- Centre for Microscopy and Microanalysis, University of Queensland, Brisbane, Queensland, Australia
| | - Maria Kavallaris
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Tumour Biology and Targeting Program, Children's Cancer Institute, Lowy Cancer Research Centre, The University of New South Wales, Sydney, New South Wales, Australia
- School of Chemistry, Australian Centre for NanoMedicine, The University of New South Wales, Sydney, New South Wales, Australia
| | - Angus P R Johnston
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia
| | - J Justin Gooding
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- School of Chemistry, Australian Centre for NanoMedicine, The University of New South Wales, Sydney, New South Wales, Australia
| | - Simon R Corrie
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia
- Department of Chemical Engineering, Monash University, Clayton, Victoria, Australia
| | - Ben J Boyd
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia
| | - Pall Thordarson
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- School of Chemistry, Australian Centre for NanoMedicine, The University of New South Wales, Sydney, New South Wales, Australia
| | - Andrew K Whittaker
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia
| | - Molly M Stevens
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Department of Materials, Imperial College London, London, UK
- Department of Bioengineering, and Institute of Biomedical Engineering, Imperial College London, London, UK
| | - Clive A Prestidge
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- School of Pharmacy and Medical Science, The University of South Australia, Adelaide, South Australia, Australia
| | - Christopher J H Porter
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia
| | - Wolfgang J Parak
- Fachbereich Physik und Chemie, CHyN, Universität Hamburg, Hamburg, Germany
- Institute of Nano Biomedicine and Engineering, Shanghai Engineering Research Center for Intelligent Diagnosis and Treatment Instrument, Key Laboratory for Thin Film and Microfabrication Technology of the Ministry of Education, Department of Instrument Science and Engineering, School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai, China
| | - Thomas P Davis
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia
- Department of Chemistry, University of Warwick, Coventry, UK
| | - Edmund J Crampin
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia, .
- Systems Biology Laboratory, School of Mathematics and Statistics and Melbourne School of Engineering, The University of Melbourne, Parkville, Victoria, Australia.
| | - Frank Caruso
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia, .
- Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria, Australia.
| |
Collapse
|
13
|
|
14
|
Wills JW, Summers HD, Hondow N, Sooresh A, Meissner KE, White PA, Rees P, Brown A, Doak SH. Characterizing Nanoparticles in Biological Matrices: Tipping Points in Agglomeration State and Cellular Delivery In Vitro. ACS NANO 2017; 11:11986-12000. [PMID: 29072897 DOI: 10.1021/acsnano.7b03708] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
Abstract
Understanding the delivered cellular dose of nanoparticles is imperative in nanomedicine and nanosafety, yet is known to be extremely complex because of multiple interactions between nanoparticles, their environment, and the cells. Here, we use 3-D reconstruction of agglomerates preserved by cryogenic snapshot sampling and imaged by electron microscopy to quantify the "bioavailable dose" that is presented at the cell surface and formed by the process of individual nanoparticle sequestration into agglomerates in the exposure media. Critically, using 20 and 40 nm carboxylated polystyrene-latex and 16 and 85 nm silicon dioxide nanoparticles, we show that abrupt, dose-dependent "tipping points" in agglomeration state can arise, subsequently affecting cellular delivery and increasing toxicity. These changes are triggered by shifts in the ratio of the total nanoparticle surface area to biomolecule abundance, with the switch to a highly agglomerated state effectively changing the test article midassay, challenging the dose-response paradigm for nanosafety experiments. By characterizing nanoparticle numbers per agglomerate, we show these tipping points can lead to the formation of extreme agglomeration states whereby 90% of an administered dose is contained and delivered to the cells by just the top 2% of the largest agglomerates. We thus demonstrate precise definition, description, and comparison of the nanoparticle dose formed in different experimental environments and show that this description is critical to understanding cellular delivery and toxicity. We further empirically "stress-test" the commonly used dynamic light scattering approach, establishing its limitations to present an analysis strategy that significantly improves the usefulness of this popular nanoparticle characterization technique.
Collapse
Affiliation(s)
- John W Wills
- Institute of Life Sciences, Swansea University Medical School , Singleton Park, Swansea, SA2 8PP, U.K
| | - Huw D Summers
- Centre for Nanohealth, Swansea University College of Engineering , Fabian Way, Crymlyn Burrows, Swansea, SA1 8EN, U.K
| | - Nicole Hondow
- School of Chemical and Process Engineering, University of Leeds , Leeds, LS2 9JT, U.K
| | - Aishwarya Sooresh
- Department of Materials Science and Engineering, Texas A&M University , College Station, Texas 77843, United States
| | - Kenith E Meissner
- Department of Biomedical Engineering, Texas A&M University , College Station, Texas 77843, United States
- Department of Physics, Swansea University College of Science , Singleton Park, Swansea, SA2 8PP, U.K
| | - Paul A White
- Department of Biology, University of Ottawa , 30 Marie-Curie Private, Ottawa K1N 9B4, Ontario, Canada
| | - Paul Rees
- Centre for Nanohealth, Swansea University College of Engineering , Fabian Way, Crymlyn Burrows, Swansea, SA1 8EN, U.K
- Broad Institute of MIT and Harvard , 415 Main Street, Cambridge, Massachusetts 02142, United States
| | - Andy Brown
- School of Chemical and Process Engineering, University of Leeds , Leeds, LS2 9JT, U.K
| | - Shareen H Doak
- Institute of Life Sciences, Swansea University Medical School , Singleton Park, Swansea, SA2 8PP, U.K
| |
Collapse
|
15
|
Vazquez-Muñoz R, Borrego B, Juárez-Moreno K, García-García M, Mota Morales JD, Bogdanchikova N, Huerta-Saquero A. Toxicity of silver nanoparticles in biological systems: Does the complexity of biological systems matter? Toxicol Lett 2017; 276:11-20. [PMID: 28483428 DOI: 10.1016/j.toxlet.2017.05.007] [Citation(s) in RCA: 150] [Impact Index Per Article: 21.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2016] [Revised: 04/03/2017] [Accepted: 05/05/2017] [Indexed: 12/20/2022]
Abstract
Currently, nanomaterials are more frequently in our daily life, specifically in biomedicine, electronics, food, textiles and catalysis just to name a few. Although nanomaterials provide many benefits, recently their toxicity profiles have begun to be explored. In this work, the toxic effects of silver nanoparticles (35nm-average diameter and Polyvinyl-Pyrrolidone-coated) on biological systems of different levels of complexity was assessed in a comprehensive and comparatively way, through a variety of viability and toxicological assays. The studied organisms included viruses, bacteria, microalgae, fungi, animal and human cells (including cancer cell lines). It was found that biological systems of different taxonomical groups are inhibited at concentrations of silver nanoparticles within the same order of magnitude. Thus, the toxicity of nanomaterials on biological/living systems, constrained by their complexity, e.g. taxonomic groups, resulted contrary to the expected. The fact that cells and virus are inhibited with a concentration of silver nanoparticles within the same order of magnitude could be explained considering that silver nanoparticles affects very primitive cellular mechanisms by interacting with fundamental structures for cells and virus alike.
Collapse
Affiliation(s)
- Roberto Vazquez-Muñoz
- Centro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México, Km 107 Carretera Tijuana-Ensenada, CP 22860, Ensenada, Baja California, Mexico; Centro de Investigación Científica y de Educación Superior de Ensenada, Carretera Tijuana-Ensenada 3918, CP 22860, Ensenada, Baja California, Mexico
| | - Belen Borrego
- Centro de Investigación en Sanidad Animal, INIA (National Research Institute for Agricultural and Food Technology), Carretera Algete el Casar s/n, 28130, Valdeolmos, Madrid, Spain
| | - Karla Juárez-Moreno
- Centro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México, Km 107 Carretera Tijuana-Ensenada, CP 22860, Ensenada, Baja California, Mexico
| | - Maritza García-García
- Centro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México, Km 107 Carretera Tijuana-Ensenada, CP 22860, Ensenada, Baja California, Mexico
| | - Josué D Mota Morales
- Centro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México, Km 107 Carretera Tijuana-Ensenada, CP 22860, Ensenada, Baja California, Mexico; Centro de Física Aplicada y Tecnología Avanzada, Universidad Nacional Autónoma de México, Querétaro, Querétaro 76230, Mexico
| | - Nina Bogdanchikova
- Centro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México, Km 107 Carretera Tijuana-Ensenada, CP 22860, Ensenada, Baja California, Mexico
| | - Alejandro Huerta-Saquero
- Centro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México, Km 107 Carretera Tijuana-Ensenada, CP 22860, Ensenada, Baja California, Mexico.
| |
Collapse
|
16
|
Attota RK, Liu EC. Volume determination of irregularly-shaped quasi-spherical nanoparticles. Anal Bioanal Chem 2016; 408:7897-7903. [PMID: 27659817 DOI: 10.1007/s00216-016-9909-x] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2016] [Revised: 08/22/2016] [Accepted: 08/26/2016] [Indexed: 10/21/2022]
Abstract
Nanoparticles (NPs) are widely used in diverse application areas, such as medicine, engineering, and cosmetics. The size (or volume) of NPs is one of the most important parameters for their successful application. It is relatively straightforward to determine the volume of regular NPs such as spheres and cubes from a one-dimensional or two-dimensional measurement. However, due to the three-dimensional nature of NPs, it is challenging to determine the proper physical size of many types of regularly and irregularly-shaped quasi-spherical NPs at high-throughput using a single tool. Here, we present a relatively simple method that determines a better volume estimate of NPs by combining measurements from their top-down projection areas and peak heights using two tools. The proposed method is significantly faster and more economical than the electron tomography method. We demonstrate the improved accuracy of the combined method over scanning electron microscopy (SEM) or atomic force microscopy (AFM) alone by using modeling, simulations, and measurements. This study also exposes the existence of inherent measurement biases for both SEM and AFM, which usually produce larger measured diameters with SEM than with AFM. However, in some cases SEM measured diameters appear to have less error compared to AFM measured diameters, especially for widely used IS-NPs such as of gold, and silver. The method provides a much needed, proper high-throughput volumetric measurement method useful for many applications. Graphical Abstract The combined method for volume determination of irregularly-shaped quasi-spherical nanoparticles.
Collapse
Affiliation(s)
- Ravi Kiran Attota
- Engineering Physics Division, Physical Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, MD, 20899, USA.
| | - Eileen Cherry Liu
- Engineering Physics Division, Physical Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, MD, 20899, USA
| |
Collapse
|
17
|
Rischitor G, Parracino M, La Spina R, Urbán P, Ojea-Jiménez I, Bellido E, Valsesia A, Gioria S, Capomaccio R, Kinsner-Ovaskainen A, Gilliland D, Rossi F, Colpo P. Quantification of the cellular dose and characterization of nanoparticle transport during in vitro testing. Part Fibre Toxicol 2016; 13:47. [PMID: 27557953 PMCID: PMC4995798 DOI: 10.1186/s12989-016-0157-1] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2016] [Accepted: 08/12/2016] [Indexed: 01/08/2023] Open
Abstract
BACKGROUND The constant increase of the use of nanomaterials in consumer products is making increasingly urgent that standardized and reliable in vitro test methods for toxicity screening be made available to the scientific community. For this purpose, the determination of the cellular dose, i.e. the amount of nanomaterials effectively in contact with the cells is fundamental for a trustworthy determination of nanomaterial dose responses. This has often been overlooked in the literature making it difficult to undertake a comparison of datasets from different studies. Characterization of the mechanisms involved in nanomaterial transport and the determination of the cellular dose is essential for the development of predictive numerical models and reliable in vitro screening methods. RESULTS This work aims to relate key physico-chemical properties of gold nanoparticles (NPs) to the kinetics of their deposition on the cellular monolayer. Firstly, an extensive characterization of NPs in complete culture cell medium was performed to determine the diameter and the apparent mass density of the formed NP-serum protein complexes. Subsequently, the kinetics of deposition were studied by UV-vis absorbance measurements in the presence or absence of cells. The fraction of NPs deposited on the cellular layer was found to be highly dependent on NP size and apparent density because these two parameters influence the NP transport. The NP deposition occurred in two phases: phase 1, which consists of cellular uptake driven by the NP-cell affinity, and phase 2 consisting mainly of NP deposition onto the cellular membrane. CONCLUSION The fraction of deposited NPs is very different from the initial concentration applied in the in vitro assay, and is highly dependent of the size and density of the NPs, on the associated transport rate and on the exposure duration. This study shows that an accurate characterization is needed and suitable experimental conditions such as initial concentration of NPs and liquid height in the wells has to be considered since they strongly influence the cellular dose and the nature of interactions of NPs with the cells.
Collapse
Affiliation(s)
- Grigore Rischitor
- European Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027 Ispra, VA Italy
| | | | - Rita La Spina
- European Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027 Ispra, VA Italy
| | - Patrizia Urbán
- European Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027 Ispra, VA Italy
| | - Isaac Ojea-Jiménez
- European Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027 Ispra, VA Italy
| | - Elena Bellido
- European Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027 Ispra, VA Italy
| | - Andrea Valsesia
- European Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027 Ispra, VA Italy
| | - Sabrina Gioria
- European Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027 Ispra, VA Italy
| | - Robin Capomaccio
- European Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027 Ispra, VA Italy
| | - Agnieszka Kinsner-Ovaskainen
- European Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027 Ispra, VA Italy
| | - Douglas Gilliland
- European Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027 Ispra, VA Italy
| | - François Rossi
- European Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027 Ispra, VA Italy
| | - Pascal Colpo
- European Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027 Ispra, VA Italy
| |
Collapse
|
18
|
Holden PA, Gardea-Torresdey J, Klaessig F, Turco RF, Mortimer M, Hund-Rinke K, Hubal EAC, Avery D, Barceló D, Behra R, Cohen Y, Deydier-Stephan L, Lee Ferguson P, Fernandes TF, Harthorn BH, Henderson WM, Hoke RA, Hristozov D, Johnston JM, Kane AB, Kapustka L, Keller AA, Lenihan HS, Lovell W, Murphy CJ, Nisbet RM, Petersen EJ, Salinas ER, Scheringer M, Sharma M, Speed DE, Sultan Y, Westerhoff P, White JC, Wiesner MR, Wong EM, Xing B, Horan MS, Godwin HA, Nel AE. Considerations of Environmentally Relevant Test Conditions for Improved Evaluation of Ecological Hazards of Engineered Nanomaterials. ENVIRONMENTAL SCIENCE & TECHNOLOGY 2016; 50:6124-45. [PMID: 27177237 PMCID: PMC4967154 DOI: 10.1021/acs.est.6b00608] [Citation(s) in RCA: 114] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/18/2023]
Abstract
Engineered nanomaterials (ENMs) are increasingly entering the environment with uncertain consequences including potential ecological effects. Various research communities view differently whether ecotoxicological testing of ENMs should be conducted using environmentally relevant concentrations-where observing outcomes is difficult-versus higher ENM doses, where responses are observable. What exposure conditions are typically used in assessing ENM hazards to populations? What conditions are used to test ecosystem-scale hazards? What is known regarding actual ENMs in the environment, via measurements or modeling simulations? How should exposure conditions, ENM transformation, dose, and body burden be used in interpreting biological and computational findings for assessing risks? These questions were addressed in the context of this critical review. As a result, three main recommendations emerged. First, researchers should improve ecotoxicology of ENMs by choosing test end points, duration, and study conditions-including ENM test concentrations-that align with realistic exposure scenarios. Second, testing should proceed via tiers with iterative feedback that informs experiments at other levels of biological organization. Finally, environmental realism in ENM hazard assessments should involve greater coordination among ENM quantitative analysts, exposure modelers, and ecotoxicologists, across government, industry, and academia.
Collapse
Affiliation(s)
- Patricia A. Holden
- Bren School of Environmental Science and Management, University of California, Santa Barbara, California 93106, United States
- University of California Center for Environmental Implications of Nanotechnology (UC CEIN), University of California, Los Angeles, California 90095, United States
| | - Jorge Gardea-Torresdey
- University of California Center for Environmental Implications of Nanotechnology (UC CEIN), University of California, Los Angeles, California 90095, United States
- Department of Chemistry, Environmental Science and Engineering PhD Program, University of Texas, El Paso, Texas 79968, United States
| | - Fred Klaessig
- University of California Center for Environmental Implications of Nanotechnology (UC CEIN), University of California, Los Angeles, California 90095, United States
- Pennsylvania Bio Nano Systems, Doylestown, Pennsylvania 18901, United States
| | - Ronald F. Turco
- College of Agriculture, Laboratory for Soil Microbiology, Purdue University, West Lafayette, Indiana 47907, United States
| | - Monika Mortimer
- Bren School of Environmental Science and Management, University of California, Santa Barbara, California 93106, United States
- University of California Center for Environmental Implications of Nanotechnology (UC CEIN), University of California, Los Angeles, California 90095, United States
- Laboratory of Environmental Toxicology, National Institute of Chemical Physics and Biophysics, Akadeemia tee 23, 12618 Tallinn, Estonia
| | - Kerstin Hund-Rinke
- Fraunhofer Institute for Molecular Biology and Applied Ecology, D-57392 Schmallenberg, Germany
| | - Elaine A. Cohen Hubal
- Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27711, United States
| | - David Avery
- University of California Center for Environmental Implications of Nanotechnology (UC CEIN), University of California, Los Angeles, California 90095, United States
| | - Damià Barceló
- Department of Environmental Chemistry, Institute of Environmental Assessment and Water Research (IDAEA-CSIC), Barcelona 08034, Spain
- Institut Català de Recerca de l’Aigua (ICRA), Parc Científic i Tecnològic de la Universitat de Girona, Girona 17003, Spain
| | - Renata Behra
- Eawag, Swiss Federal Institute of Aquatic Science and Technology, 8600 Dübendorf, Switzerland
- Institute of Biogeochemistry and Pollutant Dynamics, ETH Zürich, 8092 Zürich, Switzerland
| | - Yoram Cohen
- University of California Center for Environmental Implications of Nanotechnology (UC CEIN), University of California, Los Angeles, California 90095, United States
- California NanoSystems Institute, University of California Los Angeles, California 90095, United States
- Chemical and Biomolecular Engineering Department, University of California Los Angeles, California 90095, United States
| | | | - Patrick Lee Ferguson
- Department of Civil & Environmental Engineering, Duke University, Durham, North Carolina 27708, United States
- Center for the Environmental Implications of NanoTechnology (CEINT), Duke University, Durham, North Carolina 27708, United States
| | | | - Barbara Herr Harthorn
- University of California Center for Environmental Implications of Nanotechnology (UC CEIN), University of California, Los Angeles, California 90095, United States
- Center for Nanotechnology in Society, University of California, Santa Barbara, California 93106
- Department of Anthropology, University of California, Santa Barbara, California 93106
| | - William Matthew Henderson
- Office of Research and Development, National Exposure Research Laboratory, U.S. Environmental Protection Agency, Athens, Georgia 30605, United States
| | - Robert A. Hoke
- E.I. du Pont de Nemours and Company, Newark, Delaware 19711, United States
| | - Danail Hristozov
- Department of Environmental Sciences, Informatics and Statistics, University Ca' Foscari Venice, Venice 30123, Italy
| | - John M. Johnston
- Office of Research and Development, National Exposure Research Laboratory, U.S. Environmental Protection Agency, Athens, Georgia 30605, United States
| | - Agnes B. Kane
- Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island 02912, United States
| | | | - Arturo A. Keller
- Bren School of Environmental Science and Management, University of California, Santa Barbara, California 93106, United States
- University of California Center for Environmental Implications of Nanotechnology (UC CEIN), University of California, Los Angeles, California 90095, United States
| | - Hunter S. Lenihan
- Bren School of Environmental Science and Management, University of California, Santa Barbara, California 93106, United States
- University of California Center for Environmental Implications of Nanotechnology (UC CEIN), University of California, Los Angeles, California 90095, United States
| | - Wess Lovell
- Vive Crop Protection Inc, Toronto, Ontario M5G 1L6, Canada
| | - Catherine J. Murphy
- Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States
| | - Roger M. Nisbet
- University of California Center for Environmental Implications of Nanotechnology (UC CEIN), University of California, Los Angeles, California 90095, United States
- Department of Ecology, Evolution and Marine Biology, University of California, Santa Barbara, California 93106, United States
| | - Elijah J. Petersen
- Biosystems and Biomaterials Division, Material Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States
| | - Edward R. Salinas
- BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, D-67056, Germany
| | - Martin Scheringer
- Institute for Chemical and Bioengineering, ETH Zürich, 8093 Zürich, Switzerland
| | - Monita Sharma
- PETA International Science Consortium, Ltd., London N1 9RL, England, United Kingdom
| | - David E. Speed
- Globalfoundries, Corporate EHS, Hopewell Junction, New York 12533, United States
| | - Yasir Sultan
- Environment Canada, Gatineau, Quebec J8X 4C8, Canada
| | - Paul Westerhoff
- School of Sustainable Engineering and the Built Environment, Arizona State University, Tempe, Arizona 85287, United States
| | - Jason C. White
- Department of Analytical Chemistry, The Connecticut Agricultural Experiment Station, New Haven, Connecticut 06504, United States
| | - Mark R. Wiesner
- Department of Civil & Environmental Engineering, Duke University, Durham, North Carolina 27708, United States
- Center for the Environmental Implications of NanoTechnology (CEINT), Duke University, Durham, North Carolina 27708, United States
| | - Eva M. Wong
- Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Washington, D.C. 20460, United States
| | - Baoshan Xing
- Stockbridge School of Agriculture, University of Massachusetts, Amherst, Massachusetts 01003, United States
| | - Meghan Steele Horan
- University of California Center for Environmental Implications of Nanotechnology (UC CEIN), University of California, Los Angeles, California 90095, United States
| | - Hilary A. Godwin
- University of California Center for Environmental Implications of Nanotechnology (UC CEIN), University of California, Los Angeles, California 90095, United States
- California NanoSystems Institute, University of California Los Angeles, California 90095, United States
- Department of Environmental Health Sciences, Fielding School of Public Health, University of California, Los Angeles, California 90095, United States
- Institute of the Environment and Sustainability, University of California, Los Angeles, California 90095, United States
| | - André E. Nel
- University of California Center for Environmental Implications of Nanotechnology (UC CEIN), University of California, Los Angeles, California 90095, United States
- California NanoSystems Institute, University of California Los Angeles, California 90095, United States
- Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, California 90095, United States
| |
Collapse
|
19
|
Kumar A, Dailey LA, Swedrowska M, Siow R, Mann GE, Vizcay-Barrena G, Arno M, Mudway IS, Forbes B. Quantifying the magnitude of the oxygen artefact inherent in culturing airway cells under atmospheric oxygen versus physiological levels. FEBS Lett 2016; 590:258-69. [DOI: 10.1002/1873-3468.12026] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2015] [Revised: 11/23/2015] [Accepted: 11/24/2015] [Indexed: 12/31/2022]
Affiliation(s)
- Abhinav Kumar
- Institute of Pharmaceutical Science; King's College London; UK
| | - Lea Ann Dailey
- Institute of Pharmaceutical Science; King's College London; UK
| | | | - Richard Siow
- Cardiovascular Division; British Heart Foundation Centre of Research Excellence; King's College London; UK
| | - Giovanni E. Mann
- Cardiovascular Division; British Heart Foundation Centre of Research Excellence; King's College London; UK
| | | | | | - Ian S. Mudway
- MRC-PHE Centre for Environment and Health; King's College London; UK
- NIHR Health Protection Research Unit on Environmental Hazards at King's College London in Partnership with Public Health England; London UK
| | - Ben Forbes
- Institute of Pharmaceutical Science; King's College London; UK
| |
Collapse
|
20
|
Roebben G, Kestens V, Varga Z, Charoud-Got J, Ramaye Y, Gollwitzer C, Bartczak D, Geißler D, Noble J, Mazoua S, Meeus N, Corbisier P, Palmai M, Mihály J, Krumrey M, Davies J, Resch-Genger U, Kumarswami N, Minelli C, Sikora A, Goenaga-Infante H. Reference materials and representative test materials to develop nanoparticle characterization methods: the NanoChOp project case. Front Chem 2015; 3:56. [PMID: 26539428 PMCID: PMC4609882 DOI: 10.3389/fchem.2015.00056] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2015] [Accepted: 09/11/2015] [Indexed: 01/02/2023] Open
Abstract
This paper describes the production and characteristics of the nanoparticle test materials prepared for common use in the collaborative research project NanoChOp (Chemical and optical characterization of nanomaterials in biological systems), in casu suspensions of silica nanoparticles and CdSe/CdS/ZnS quantum dots (QDs). This paper is the first to illustrate how to assess whether nanoparticle test materials meet the requirements of a “reference material” (ISO Guide 30, 2015) or rather those of the recently defined category of “representative test material (RTM)” (ISO/TS 16195, 2013). The NanoChOp test materials were investigated with small-angle X-ray scattering (SAXS), dynamic light scattering (DLS), and centrifugal liquid sedimentation (CLS) to establish whether they complied with the required monomodal particle size distribution. The presence of impurities, aggregates, agglomerates, and viable microorganisms in the suspensions was investigated with DLS, CLS, optical and electron microscopy and via plating on nutrient agar. Suitability of surface functionalization was investigated with attenuated total reflection Fourier transform infrared spectrometry (ATR-FTIR) and via the capacity of the nanoparticles to be fluorescently labeled or to bind antibodies. Between-unit homogeneity and stability were investigated in terms of particle size and zeta potential. This paper shows that only based on the outcome of a detailed characterization process one can raise the status of a test material to RTM or reference material, and how this status depends on its intended use.
Collapse
Affiliation(s)
- Gert Roebben
- Institute for Reference Materials and Measurements, Joint Research Centre, European Commission Geel, Belgium
| | - Vikram Kestens
- Institute for Reference Materials and Measurements, Joint Research Centre, European Commission Geel, Belgium
| | - Zoltan Varga
- Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, Hungarian Academy of Sciences Budapest, Hungary
| | - Jean Charoud-Got
- Institute for Reference Materials and Measurements, Joint Research Centre, European Commission Geel, Belgium
| | - Yannic Ramaye
- Institute for Reference Materials and Measurements, Joint Research Centre, European Commission Geel, Belgium
| | | | | | - Daniel Geißler
- Biophotonics Division 1.10, Federal Institute for Materials Research and Testing Berlin, Germany
| | - James Noble
- Analytical Sciences, National Physical Laboratory Teddington, UK
| | - Stephane Mazoua
- Institute for Reference Materials and Measurements, Joint Research Centre, European Commission Geel, Belgium
| | - Nele Meeus
- Institute for Reference Materials and Measurements, Joint Research Centre, European Commission Geel, Belgium
| | - Philippe Corbisier
- Institute for Reference Materials and Measurements, Joint Research Centre, European Commission Geel, Belgium
| | - Marcell Palmai
- Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, Hungarian Academy of Sciences Budapest, Hungary
| | - Judith Mihály
- Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, Hungarian Academy of Sciences Budapest, Hungary
| | | | | | - Ute Resch-Genger
- Biophotonics Division 1.10, Federal Institute for Materials Research and Testing Berlin, Germany
| | | | - Caterina Minelli
- Analytical Sciences, National Physical Laboratory Teddington, UK
| | - Aneta Sikora
- Analytical Sciences, National Physical Laboratory Teddington, UK
| | | |
Collapse
|
21
|
Fadeel B, Fornara A, Toprak MS, Bhattacharya K. Keeping it real: The importance of material characterization in nanotoxicology. Biochem Biophys Res Commun 2015; 468:498-503. [PMID: 26187673 DOI: 10.1016/j.bbrc.2015.06.178] [Citation(s) in RCA: 43] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2015] [Accepted: 06/23/2015] [Indexed: 12/12/2022]
Abstract
Nanomaterials are small and the small size and corresponding large surface area of nanomaterials confers specific properties, making these materials desirable for various applications, not least in medicine. However, it is pertinent to ask whether size is the only property that matters for the desirable or detrimental effects of nanomaterials? Indeed, it is important to know not only what the material looks like, but also what it is made of, as well as how the material interacts with its biological surroundings. It has been suggested that guidelines should be implemented on the types of information required in terms of physicochemical characterization of nanomaterials for toxicological studies in order to improve the quality and relevance of the published results. This is certainly a key issue, but it is important to keep in mind that material characterization should be fit-for-purpose, that is, the information gathered should be relevant for the end-points being studied.
Collapse
Affiliation(s)
- Bengt Fadeel
- Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.
| | - Andrea Fornara
- Unit for Chemistry, Materials and Surfaces, SP Technical Research Institute of Sweden, 114 86 Stockholm, Sweden
| | - Muhammet S Toprak
- Functional Materials Division, Department of Materials and Nano Physics, Royal Institute of Technology, 164 40 Stockholm, Sweden
| | - Kunal Bhattacharya
- Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden
| |
Collapse
|
22
|
Nel AE, Parak WJ, Chan WCW, Xia T, Hersam MC, Brinker CJ, Zink JI, Pinkerton KE, Baer DR, Weiss PS. Where Are We Heading in Nanotechnology Environmental Health and Safety and Materials Characterization? ACS NANO 2015; 9:5627-30. [PMID: 26100220 DOI: 10.1021/acsnano.5b03496] [Citation(s) in RCA: 57] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
|
23
|
Chen CW, Hsu CY, Lai SM, Syu WJ, Wang TY, Lai PS. Metal nanobullets for multidrug resistant bacteria and biofilms. Adv Drug Deliv Rev 2014; 78:88-104. [PMID: 25138828 DOI: 10.1016/j.addr.2014.08.004] [Citation(s) in RCA: 82] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2013] [Revised: 06/27/2014] [Accepted: 08/11/2014] [Indexed: 12/19/2022]
Abstract
Infectious diseases were one of the major causes of mortality until now because drug-resistant bacteria have arisen under broad use and abuse of antibacterial drugs. These multidrug-resistant bacteria pose a major challenge to the effective control of bacterial infections and this threat has prompted the development of alternative strategies to treat bacterial diseases. Recently, use of metallic nanoparticles (NPs) as antibacterial agents is one of the promising strategies against bacterial drug resistance. This review first describes mechanisms of bacterial drug resistance and then focuses on the properties and applications of metallic NPs as antibiotic agents to deal with antibiotic-sensitive and -resistant bacteria. We also provide an overview of metallic NPs as bactericidal agents combating antibiotic-resistant bacteria and their potential in vivo toxicology for further drug development.
Collapse
Affiliation(s)
- Ching-Wen Chen
- Department of Chemistry, National Chung Hsing University, 250, Kuo Kuang Rd., Taichung 402, Taiwan
| | - Chia-Yen Hsu
- Department of Chemistry, National Chung Hsing University, 250, Kuo Kuang Rd., Taichung 402, Taiwan
| | - Syu-Ming Lai
- Department of Chemistry, National Chung Hsing University, 250, Kuo Kuang Rd., Taichung 402, Taiwan
| | - Wei-Jhe Syu
- Department of Chemistry, National Chung Hsing University, 250, Kuo Kuang Rd., Taichung 402, Taiwan
| | - Ting-Yi Wang
- Department of Chemistry, National Chung Hsing University, 250, Kuo Kuang Rd., Taichung 402, Taiwan
| | - Ping-Shan Lai
- Department of Chemistry, National Chung Hsing University, 250, Kuo Kuang Rd., Taichung 402, Taiwan; Research Center for Sustainable Energy and Nanotechnology, National Chung Hsing University, 250, Kuo Kuang Rd., Taichung 402, Taiwan.
| |
Collapse
|
24
|
Kim JA, Salvati A, Åberg C, Dawson KA. Suppression of nanoparticle cytotoxicity approaching in vivo serum concentrations: limitations of in vitro testing for nanosafety. NANOSCALE 2014; 6:14180-4. [PMID: 25340311 DOI: 10.1039/c4nr04970e] [Citation(s) in RCA: 57] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
Nanomaterials challenge paradigms of in vitro testing because unlike molecular species, biomolecules in the dispersion medium modulate their interactions with cells. Exposing cells to nanoparticles known to cause cell death, we observed cytotoxicity suppression by increasing the amount of serum in the dispersion medium towards in vivo-relevant conditions.
Collapse
Affiliation(s)
- Jong Ah Kim
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology and Conway Institute for Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland.
| | | | | | | |
Collapse
|
25
|
Gonzalo S, Llaneza V, Pulido-Reyes G, Fernández-Piñas F, Bonzongo JC, Leganes F, Rosal R, García-Calvo E, Rodea-Palomares I. A colloidal singularity reveals the crucial role of colloidal stability for nanomaterials in-vitro toxicity testing: nZVI-microalgae colloidal system as a case study. PLoS One 2014; 9:e109645. [PMID: 25340509 PMCID: PMC4207682 DOI: 10.1371/journal.pone.0109645] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2014] [Accepted: 08/21/2014] [Indexed: 11/18/2022] Open
Abstract
Aggregation raises attention in Nanotoxicology due to its methodological implications. Aggregation is a physical symptom of a more general physicochemical condition of colloidal particles, namely, colloidal stability. Colloidal stability is a global indicator of the tendency of a system to reduce its net surface energy, which may be achieved by homo-aggregation or hetero-aggregation, including location at bio-interfaces. However, the role of colloidal stability as a driver of ENM bioactivity has received little consideration thus far. In the present work, which focuses on the toxicity of nanoscaled Fe° nanoparticles (nZVI) towards a model microalga, we demonstrate that colloidal stability is a fundamental driver of ENM bioactivity, comprehensively accounting for otherwise inexplicable differential biological effects. The present work throws light on basic aspects of Nanotoxicology, and reveals a key factor which may reconcile contradictory results on the influence of aggregation in bioactivity of ENMs.
Collapse
Affiliation(s)
- Soledad Gonzalo
- Departamento de Ingeniería Química, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain
| | - Veronica Llaneza
- Department of Environmental Engineering Sciences, University of Florida, Gainesville, Florida, United States of America
| | - Gerardo Pulido-Reyes
- Departamento de Ingeniería Química, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain
- Departamento de Biología, Facultad de Ciencias, Universidad Autónoma de Madrid, Madrid, Spain
| | | | - Jean Claude Bonzongo
- Department of Environmental Engineering Sciences, University of Florida, Gainesville, Florida, United States of America
| | - Francisco Leganes
- Departamento de Biología, Facultad de Ciencias, Universidad Autónoma de Madrid, Madrid, Spain
| | - Roberto Rosal
- Departamento de Ingeniería Química, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain
- Instituto Madrileño de Estudios Avanzados (IMDEA) Agua, Alcalá de Henares, Madrid, Spain
| | - Eloy García-Calvo
- Departamento de Ingeniería Química, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain
- Instituto Madrileño de Estudios Avanzados (IMDEA) Agua, Alcalá de Henares, Madrid, Spain
| | - Ismael Rodea-Palomares
- Departamento de Biología, Facultad de Ciencias, Universidad Autónoma de Madrid, Madrid, Spain
- * E-mail:
| |
Collapse
|
26
|
Manufactured nanomaterials: categorization and approaches to hazard assessment. Arch Toxicol 2014; 88:2191-211. [PMID: 25326817 DOI: 10.1007/s00204-014-1383-7] [Citation(s) in RCA: 80] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2014] [Accepted: 10/02/2014] [Indexed: 10/24/2022]
Abstract
Nanotechnology offers enormous potential for technological progress. Fortunately, early and intensive efforts have been invested in investigating toxicology and safety aspects of this new technology. However, despite there being more than 6,000 publications on nanotoxicology, some key questions still have to be answered and paradigms need to be challenged. Here, we present a view on the field of nanotoxicology to stimulate the discussion on major knowledge gaps and the critical appraisal of concepts or dogma. First, in the ongoing debate as to whether nanoparticles may harbour a specific toxicity due to their size, we support the view that there is at present no evidence of 'nanospecific' mechanisms of action; no step-change in hazard was observed so far for particles below 100 nm in one dimension. Therefore, it seems unjustified to consider all consumer products containing nanoparticles a priori as hazardous. Second, there is no evidence so far that fundamentally different biokinetics of nanoparticles would trigger toxicity. However, data are sparse whether nanoparticles may accumulate to an extent high enough to cause chronic adverse effects. To facilitate hazard assessment, we propose to group nanomaterials into three categories according to the route of exposure and mode of action, respectively: Category 1 comprises nanomaterials for which toxicity is mediated by the specific chemical properties of its components, such as released ions or functional groups on the surface. Nanomaterials belonging to this category have to be evaluated on a case-by-case basis, depending on their chemical identity. Category 2 focuses on rigid biopersistent respirable fibrous nanomaterials with a specific geometry and high aspect ratio (so-called WHO fibres). For these fibres, hazard assessment can be based on the experiences with asbestos. Category 3 focuses on respirable granular biodurable particles (GBP) which, after inhalation, may cause inflammation and secondary mutagenicity that may finally lead to lung cancer. After intravenous, oral or dermal exposure, nanoscaled GBPs investigated apparently did not show 'nanospecific' effects so far. Hazard assessment of GBPs may be based on the knowledge available for granular particles. In conclusion, we believe the proposed categorization system will facilitate future hazard assessments.
Collapse
|
27
|
Lison D, Vietti G, van den Brule S. Paracelsus in nanotoxicology. Part Fibre Toxicol 2014; 11:35. [PMID: 25138533 PMCID: PMC4354280 DOI: 10.1186/s12989-014-0035-7] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2014] [Accepted: 07/28/2014] [Indexed: 02/06/2023] Open
Affiliation(s)
- Dominique Lison
- Louvain Centre for Toxicology and Applied Pharmacology, Brussels, Belgium.
| | - Giulia Vietti
- Louvain Centre for Toxicology and Applied Pharmacology, Brussels, Belgium.
| | | |
Collapse
|
28
|
Ware MJ, Godin B, Singh N, Majithia R, Shamsudeen S, Serda RE, Meissner KE, Rees P, Summers HD. Analysis of the influence of cell heterogeneity on nanoparticle dose response. ACS NANO 2014; 8:6693-700. [PMID: 24923782 PMCID: PMC4216222 DOI: 10.1021/nn502356f] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/10/2014] [Accepted: 06/12/2014] [Indexed: 05/22/2023]
Abstract
Understanding the effect of variability in the interaction of individual cells with nanoparticles on the overall response of the cell population to a nanoagent is a fundamental challenge in bionanotechnology. Here, we show that the technique of time-resolved, high-throughput microscopy can be used in this endeavor. Mass measurement with single-cell resolution provides statistically robust assessments of cell heterogeneity, while the addition of a temporal element allows assessment of separate processes leading to deconvolution of the effects of particle supply and biological response. We provide a specific demonstration of the approach, in vitro, through time-resolved measurement of fibroblast cell (HFF-1) death caused by exposure to cationic nanoparticles. The results show that heterogeneity in cell area is the major source of variability with area-dependent nanoparticle capture rates determining the time of cell death and hence the form of the exposure–response characteristic. Moreover, due to the particulate nature of the nanoparticle suspension, there is a reduction in the particle concentration over the course of the experiment, eventually causing saturation in the level of measured biological outcome. A generalized mathematical description of the system is proposed, based on a simple model of particle depletion from a finite supply reservoir. This captures the essential aspects of the nanoparticle–cell interaction dynamics and accurately predicts the population exposure–response curves from individual cell heterogeneity distributions.
Collapse
Affiliation(s)
- Matthew J. Ware
- Centre for Nanohealth, College of Engineering and College of Medicine, Swansea University, Swansea SA2 8PP, U.K.
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas 77030, United States
| | - Biana Godin
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas 77030, United States
| | - Neenu Singh
- Centre for Nanohealth, College of Engineering and College of Medicine, Swansea University, Swansea SA2 8PP, U.K.
| | - Ravish Majithia
- Department of Surgery, Baylor College of Medicine, 6501 Fannin Street, Houston, Texas 77030, United States
| | - Sabeel Shamsudeen
- Centre for Nanohealth, College of Engineering and College of Medicine, Swansea University, Swansea SA2 8PP, U.K.
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas 77030, United States
| | - Rita E. Serda
- Centre for Nanohealth, College of Engineering and College of Medicine, Swansea University, Swansea SA2 8PP, U.K.
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas 77030, United States
- Department of Surgery, Baylor College of Medicine, 6501 Fannin Street, Houston, Texas 77030, United States
| | - Kenith E. Meissner
- Department of Biomedical Engineering, Texas A&M University, College Station, Texas 77843, United States
| | - Paul Rees
- Centre for Nanohealth, College of Engineering and College of Medicine, Swansea University, Swansea SA2 8PP, U.K.
- Broad Institute of MIT and Harvard, Cambridge, Boston, Massachusetts 02148, United States
| | - Huw D. Summers
- Centre for Nanohealth, College of Engineering and College of Medicine, Swansea University, Swansea SA2 8PP, U.K.
- Address correspondence to
| |
Collapse
|
29
|
Skotland T, Iversen TG, Sandvig K. Development of nanoparticles for clinical use. Nanomedicine (Lond) 2014; 9:1295-9. [DOI: 10.2217/nnm.14.81] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
Affiliation(s)
- Tore Skotland
- Centre for Cancer Biomedicine, Faculty Division Norwegian Radium Hospital, University of Oslo, Oslo, Norway
- Department of Biochemistry, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379 Oslo, Norway
| | - Tore-Geir Iversen
- Centre for Cancer Biomedicine, Faculty Division Norwegian Radium Hospital, University of Oslo, Oslo, Norway
- Department of Biochemistry, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379 Oslo, Norway
| | - Kirsten Sandvig
- Centre for Cancer Biomedicine, Faculty Division Norwegian Radium Hospital, University of Oslo, Oslo, Norway
- Department of Biochemistry, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379 Oslo, Norway
- Department of Biosciences, University of Oslo, 0316 Oslo, Norway
| |
Collapse
|
30
|
A better spin on organic semiconductors. NATURE NANOTECHNOLOGY 2013; 8:611. [PMID: 24002070 DOI: 10.1038/nnano.2013.187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
|
31
|
|
32
|
Bondarenko O, Juganson K, Ivask A, Kasemets K, Mortimer M, Kahru A. Toxicity of Ag, CuO and ZnO nanoparticles to selected environmentally relevant test organisms and mammalian cells in vitro: a critical review. Arch Toxicol 2013; 87:1181-200. [PMID: 23728526 PMCID: PMC3677982 DOI: 10.1007/s00204-013-1079-4] [Citation(s) in RCA: 675] [Impact Index Per Article: 61.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2013] [Accepted: 05/08/2013] [Indexed: 11/26/2022]
Abstract
Nanoparticles (NPs) of copper oxide (CuO), zinc oxide (ZnO) and especially nanosilver are intentionally used to fight the undesirable growth of bacteria, fungi and algae. Release of these NPs from consumer and household products into waste streams and further into the environment may, however, pose threat to the 'non-target' organisms, such as natural microbes and aquatic organisms. This review summarizes the recent research on (eco)toxicity of silver (Ag), CuO and ZnO NPs. Organism-wise it focuses on key test species used for the analysis of ecotoxicological hazard. For comparison, the toxic effects of studied NPs toward mammalian cells in vitro were addressed. Altogether 317 L(E)C50 or minimal inhibitory concentrations (MIC) values were obtained for algae, crustaceans, fish, bacteria, yeast, nematodes, protozoa and mammalian cell lines. As a rule, crustaceans, algae and fish proved most sensitive to the studied NPs. The median L(E)C50 values of Ag NPs, CuO NPs and ZnO NPs (mg/L) were 0.01, 2.1 and 2.3 for crustaceans; 0.36, 2.8 and 0.08 for algae; and 1.36, 100 and 3.0 for fish, respectively. Surprisingly, the NPs were less toxic to bacteria than to aquatic organisms: the median MIC values for bacteria were 7.1, 200 and 500 mg/L for Ag, CuO and ZnO NPs, respectively. In comparison, the respective median L(E)C50 values for mammalian cells were 11.3, 25 and 43 mg/L. Thus, the toxic range of all the three metal-containing NPs to target- and non-target organisms overlaps, indicating that the leaching of biocidal NPs from consumer products should be addressed.
Collapse
Affiliation(s)
- Olesja Bondarenko
- Laboratory of Environmental Toxicology, National Institute of Chemical Physics and Biophysics, Akadeemia tee 23, 12618 Tallinn, Estonia
| | - Katre Juganson
- Laboratory of Environmental Toxicology, National Institute of Chemical Physics and Biophysics, Akadeemia tee 23, 12618 Tallinn, Estonia
- Department of Chemistry, Tallinn University of Technology, Ehitajate tee 5, 19086 Tallinn, Estonia
| | - Angela Ivask
- Laboratory of Environmental Toxicology, National Institute of Chemical Physics and Biophysics, Akadeemia tee 23, 12618 Tallinn, Estonia
| | - Kaja Kasemets
- Laboratory of Environmental Toxicology, National Institute of Chemical Physics and Biophysics, Akadeemia tee 23, 12618 Tallinn, Estonia
| | - Monika Mortimer
- Laboratory of Environmental Toxicology, National Institute of Chemical Physics and Biophysics, Akadeemia tee 23, 12618 Tallinn, Estonia
- Aquatic Biogeochemistry and Ecotoxicology, Institute F.-A. Forel, Faculty of Sciences, University of Geneva, 10 route de Suisse, 1290 Versoix, Switzerland
| | - Anne Kahru
- Laboratory of Environmental Toxicology, National Institute of Chemical Physics and Biophysics, Akadeemia tee 23, 12618 Tallinn, Estonia
| |
Collapse
|
33
|
McCall MJ, Coleman VA, Herrmann J, Kirby JK, Gardner IR, Brent PJ, Johnson CM. A tiered approach. NATURE NANOTECHNOLOGY 2013; 8:307-308. [PMID: 23648732 DOI: 10.1038/nnano.2013.48] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
|
34
|
|
35
|
|
36
|
|
37
|
|
38
|
|
39
|
Baker NA, Klemm JD, Harper SL, Gaheen S, Heiskanen M, Rocca-Serra P, Sansone SA. Standardizing data. NATURE NANOTECHNOLOGY 2013; 8:73-74. [PMID: 23380926 PMCID: PMC4054689 DOI: 10.1038/nnano.2013.12] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Affiliation(s)
- Nathan A. Baker
- Computational and Statistical Analytics Division, Pacific Northwest
National Laboratory, MSID K7-28, PO Box 999, Richland, Washington 99352, USA
| | - Juli D. Klemm
- Center for Biomedical Informatics and Information Technology,
National Cancer Institute, Maryland 20852, USA
| | - Stacey L. Harper
- Department of Environmental and Molecular Toxicology, School of
Chemical, Biological and Environmental Engineering, Oregon State University, Oregon
97331, USA
| | - Sharon Gaheen
- SAIC-Frederick, Frederick National Laboratory for Cancer Research,
Information Systems Program, 6110 Executive Boulevard, Suite 250, Rockville,
Maryland 20852, USA
| | - Mervi Heiskanen
- Center for Biomedical Informatics and Information Technology,
National Cancer Institute, Maryland 20852, USA
| | | | | |
Collapse
|
40
|
|
41
|
|
42
|
|
43
|
Bussy C, Pinault M, Cambedouzou J, Landry MJ, Jegou P, Mayne-L'hermite M, Launois P, Boczkowski J, Lanone S. Critical role of surface chemical modifications induced by length shortening on multi-walled carbon nanotubes-induced toxicity. Part Fibre Toxicol 2012. [PMID: 23181604 PMCID: PMC3515433 DOI: 10.1186/1743-8977-9-46] [Citation(s) in RCA: 67] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Given the increasing use of carbon nanotubes (CNT) in composite materials and their possible expansion to new areas such as nanomedicine which will both lead to higher human exposure, a better understanding of their potential to cause adverse effects on human health is needed. Like other nanomaterials, the biological reactivity and toxicity of CNT were shown to depend on various physicochemical characteristics, and length has been suggested to play a critical role. We therefore designed a comprehensive study that aimed at comparing the effects on murine macrophages of two samples of multi-walled CNT (MWCNT) specifically synthesized following a similar production process (aerosol-assisted CVD), and used a soft ultrasonic treatment in water to modify the length of one of them. We showed that modification of the length of MWCNT leads, unavoidably, to accompanying structural (i.e. defects) and chemical (i.e. oxidation) modifications that affect both surface and residual catalyst iron nanoparticle content of CNT. The biological response of murine macrophages to the two different MWCNT samples was evaluated in terms of cell viability, pro-inflammatory cytokines secretion and oxidative stress. We showed that structural defects and oxidation both induced by the length reduction process are at least as responsible as the length reduction itself for the enhanced pro-inflammatory and pro-oxidative response observed with short (oxidized) compared to long (pristine) MWCNT. In conclusion, our results stress that surface properties should be considered, alongside the length, as essential parameters in CNT-induced inflammation, especially when dealing with a safe design of CNT, for application in nanomedicine for example.
Collapse
|